Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
หนังสือแจ้งการจัดสรรหุ้นสามัญเพิ่มทุน (Translation) O.C.C. Public Company Limited Information Memorandum on Acquisition of Assets October, 2017 Information Memorandum on Acquisition of Assets O.C.C
จําเปน หรือเปนขอจํากัดทางกฎหมายของแตละประเทศ (รายละเอียดตามเอกสารแนบ) การรวมมือจัดทํา ASEAN Equity Disclosure Standards ขางตน มีวัตถุประสงคหลัก เพื่อใหการระดมทุนในกลุมประเทศอาเซียนมากกวา 1
Equity Coverage Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 1 of 10 Performance Overview Growth continued both revenue and net profits, attributed to efficient
Equity Coverage Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 1 of 10 Performance Overview Continuous growth in both revenue and net profits, attributed to
on another overseas exchange simultaneously or in proximate period, on the condition that equity trading volume on such oversea exchange is higher than that on the SET. In addition, the overseas
) 1,250,000 equity shares with a par value of INR 10 per share and (2) 3,500,000 redeemable non-cumulative preference shares with a par value of INR 10. Paid-up Capital: SAAPL has a paid-up capital of INR
Capital: SAAPL has a registered capital of INR 47,500,000, divided into (1) 1,250,000 equity shares with a par value of INR 10 per share and (2) 3,500,000 redeemable non-cumulative preference shares with a
31, 2019. (Value of transaction paid x 100 / Total assets ) = 57,750,000*100/1,848,984,041.62 = 3.12 The value of equity shares issued for the payment of assets has not been applied due to the fact
1,000.00 1,000.00 Premium (Discount) on Share Capital 467.90 467.90 467.90 467.90 Retained Earnings (Deficit) 1,210.92 1,198.52 1,166.13 1,181.99 Treasury Stock - - - - Shares Of The Company Held By